Evidence map›Paper›PMID 32542039›Full record

ArticlePLoS genetics2020

Cancer-associated mutations in the iron-sulfur domain of FANCJ affect G-quadruplex metabolism.

Diana C Odermatt, Wei Ting C Lee, Sebastian Wild, Stanislaw K Jozwiakowski, Eli Rothenberg, Kerstin Gari

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Dynamic Assemblies in Genome Maintenance.Advances in experimental medicine and biology · 2026
    Review
  8. Review
  9. Why cells need iron: a compendium of iron utilisation.Trends in endocrinology and metabolism: TEM · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. G-quadruplex DNA: a novel target for drug design.Cellular and molecular life sciences : CMLS · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Diana C OdermattInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Wei Ting C LeeDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America.ORCID 0000-0002-8842-6510
Sebastian WildInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Stanislaw K JozwiakowskiInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-0553-3530
Eli RothenbergDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America.
Kerstin GariInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-1276-8941
University of Zurich · CHNew York University · US

Funding

Mechanisms of Human DNA Double-Strand Break Repair via Quantitative Single-Molecule Imaging - Equipment SupplementR35GM134947 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Eli Rothenberg · 2020 to 2026
$3.4M
Single-Molecule Studies of Non-Homologous DNA End JoiningR01GM108119 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2019
$1.7M
NIGMS NIH HHS R01 GM108119NIGMS NIH HHS R35 GM134947
6 · The paper itself

Abstract

FANCJ/BRIP1 is an iron-sulfur (FeS) cluster-binding DNA helicase involved in DNA inter-strand cross-link (ICL) repair and G-quadruplex (G4) metabolism. Mutations in FANCJ are associated with Fanconi anemia and an increased risk for developing breast and ovarian cancer. Several cancer-associated mutations are located in the FeS domain of FANCJ, but how they affect FeS cluster binding and/or FANCJ activity has remained mostly unclear. Here we show that the FeS cluster is indispensable for FANCJ's ability to unwind DNA substrates in vitro and to provide cellular resistance to agents that induce ICLs. Moreover, we find that FANCJ requires an intact FeS cluster for its ability to unfold G4 structures on the DNA template in a primer extension assay with the lagging-strand DNA polymerase delta. Surprisingly, however, FANCJ variants that are unable to bind an FeS cluster and to unwind DNA in vitro can partially suppress the formation of replisome-associated G4 structures that we observe in a FANCJ knock-out cell line. This may suggest a partially retained cellular activity of FANCJ variants with alterations in the FeS domain. On the other hand, FANCJ knock-out cells expressing FeS cluster-deficient variants display a similar-enhanced-sensitivity towards pyridostatin (PDS) and CX-5461, two agents that stabilise G4 structures, as FANCJ knock-out cells. Mutations in FANCJ that abolish FeS cluster binding may hence be predictive of an increased cellular sensitivity towards G4-stabilising agents.

Indexed as

G-QuadruplexesMutationAnimalsBinding SitesFanconi Anemia Complementation Group ProteinsHeLa CellsHumansProtein BindingRNA HelicasesSf9 CellsSpodopteraBRIP1 protein, humanFanconi Anemia Complementation Group ProteinsRNA Helicases

Identifiers

PMID32542039
PMCPMC7316351
OpenAlexW3034211129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.